ImmunoPrecise Antibodies
IPA
#9860
Rank
A$21.62 M
Marketcap
$0.70
Share price
-0.46%
Change (1 day)
-65.46%
Change (1 year)

Earnings for ImmunoPrecise Antibodies (IPA)

Earnings in 2024 (TTM): -A$33.1 Million

According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are A$17.61 Million. In 2023 the company made an earning of -A$18.63 Million, an increase over its 2022 earnings that were of -A$31.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoPrecise Antibodies from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$33.1 Million77.66%
2023 -A$18.63 Million-41.75%
2022 -A$31.98 Million63.41%
2021 -A$19.57 Million519.54%
2020 -A$3.16 Million-58.53%
2019 -A$7.62 Million37.19%
2018 -A$5.56 Million6.4%
2017 -A$5.22 Million-2968.28%
2016 A$0.18 M-614.98%
2015 -A$0.04 Million-60.32%
2014 -A$0.09 Million-186.81%
2013 A$0.1 M-166.36%
2012 -A$0.16 Million-59.28%
2011 -A$0.38 Million
2004 -A$0.23 Million-41.04%
2003 -A$0.38 Million129.66%
2002 -A$0.17 Million-32.91%
2001 -A$0.25 Million50.61%
2000 -A$0.17 Million-16.18%
1999 -A$0.2 Million-1.56%
1998 -A$0.2 Million-39.38%
1997 -A$0.33 Million